Vol 5, No 1 (2009)
Guidelines / Expert consensus
Published online: 2009-02-02
Proposal of defining colorectal cancer subpopulation potentially recommended to bevacizumab treatment. Statement of clinical oncology Advisory Board at Roche Polska Sp. z o.o.
Onkol. Prak. Klin 2009;5(1):16-19.
Abstract
Not available
References
- Khrizman P, Niland JC, ter Veer A, et al. National Comprehensive Cancer Network. Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy. Pharmacotherapy. 2008; 28(11 Pt 2): 18S–22S.
- Chase JL. Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer. Pharmacotherapy. 2008; 28(11 Pt 2): 23S–30S.